Effect of iodine upon the TRH induced release of TSH in euthyroid, hypothyroid and hyperthyroid individuals. 1976

W Waldhäusl, and H Haydl

The effects of prolonged administration of iodide upon the serum concentrations of thyrotropin (TSH), thyroxine (T4), and triiodothyronine (T3) and their response to thyrotropin releasing hormone (TRH, 400 mug i.v.) have been studied in euthyroid (n = 9) subjects, and in hypothyroid (n = 4) patients. Administration of iodide (25 mg daily for two weeks) increased in healthy subjects the basal concentrations of TSH and the release of TSH in response to TRH (p less than 0.05-0.01). Serum concentrations of T4 and T3 were reduced (T4, 6.5 +/- 0.2 mug/100 ml to 5.9 +/- 0.3 mug/100 ml; T3, 159 +/- 8.3 ng/100 ml to 145 +/- 7.3 ng/100 ml) in parallel. Responses of T4 but not of T3 to TRH were also reduced after iodide. Two out of four hypothyroid patients also showed an increased response of TSH to TRH. Changes in serum T4 and T3 were due to their low basal concentration not measureable in this group. No response of TSH, T4 or T3 to TRH was observed in hyperthyroid patients either before or after iodide treatment (708 mg daily for one week), in spite of a fall in serum T4 (25%) and T3 (50%) upon iodide administration. These observations demonstrate that small changes in serum T4 and T3 are easily monitored by the thyrotrophs in the normal or in the hypothyroid range. Conversely a reduced sensitivity of the anterior pituitary upon the administration of TRH is found in hyperthyroid patients, since even large reductions in serum T4 and T3 do not facilitate an increased response of TSH to TRH in this group.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007454 Iodides Inorganic binary compounds of iodine or the I- ion. Iodide
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013961 Thyroid Gland A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively. Thyroid,Gland, Thyroid,Glands, Thyroid,Thyroid Glands,Thyroids
D013972 Thyrotropin A glycoprotein hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Thyrotropin stimulates THYROID GLAND by increasing the iodide transport, synthesis and release of thyroid hormones (THYROXINE and TRIIODOTHYRONINE). Thyrotropin consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the pituitary glycoprotein hormones (TSH; LUTEINIZING HORMONE and FSH), but the beta subunit is unique and confers its biological specificity. Thyroid-Stimulating Hormone,TSH (Thyroid Stimulating Hormone),Thyreotropin,Thyrotrophin,Hormone, Thyroid-Stimulating,Thyroid Stimulating Hormone
D013973 Thyrotropin-Releasing Hormone A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND. Protirelin,Thyroliberin,Abbott-38579,Antepan,Proterelin Tartrate,Proterelin Tartrate Hydrate,Protirelin Tartrate (1:1),Relefact TRH,Stimu-TSH,TRH Ferring,TRH Prem,Thypinone,Thyroliberin TRH Merck,Thyrotropin-Releasing Factor,Thyrotropin-Releasing Hormone Tartrate,Abbott 38579,Abbott38579,Hydrate, Proterelin Tartrate,Prem, TRH,Stimu TSH,StimuTSH,TRH, Relefact,Tartrate Hydrate, Proterelin,Thyrotropin Releasing Factor,Thyrotropin Releasing Hormone,Thyrotropin Releasing Hormone Tartrate
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

W Waldhäusl, and H Haydl
April 1984, Acta endocrinologica,
W Waldhäusl, and H Haydl
January 1976, Hormone research,
W Waldhäusl, and H Haydl
September 2006, Journal of cardiovascular pharmacology,
W Waldhäusl, and H Haydl
March 1966, The Journal of clinical endocrinology and metabolism,
W Waldhäusl, and H Haydl
January 1980, The Indian journal of medical research,
W Waldhäusl, and H Haydl
August 1985, Endocrinologia japonica,
W Waldhäusl, and H Haydl
June 1972, Journal of animal science,
W Waldhäusl, and H Haydl
June 1972, Journal of animal science,
Copied contents to your clipboard!